Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F91XJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $119,043
Award facts
- Contract value 100% obligated
- $119,043.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $119,043.11 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 14, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031. This IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains.
Eliquis (apixaban) is an anticoagulant medication used in military and veteran healthcare systems for thromboembolic prevention and treatment. As a critical pharmaceutical vendor to the Defense Health Agency and other federal medical institutions, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill government contracts for essential prescription medications required by military treatment facilities and veteran healthcare programs. The non-competitive nature of this award reflects the established relationship and proven performance under the larger IDC vehicle, enabling efficient delivery of essential pharmaceutical commodities to support ongoing military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F91XJ?
SPE2DR26F91XJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F91XJ worth?
The government has obligated $119,043 on SPE2DR26F91XJ.
Is contract SPE2DR26F91XJ an order under another contract?
Yes. SPE2DR26F91XJ is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91XJ competed?
The extent of competition for SPE2DR26F91XJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award